Articles by Laura Bush - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Laura Bush

HGS Selects Lonza for Future Commercial Manufacture of Benlysta

Jul 14, 2010

Human Genome Sciences (HGS, Rockville, MD) has selected Lonza (Basel, Switzerland) as its contract manufacturer for the future commercial supply of Benlysta.

Bold Manufacturing Strategy Soon to Pay Off for Human Genome Sciences

Jul 7, 2010

After 18 years, Human Genome Sciences (HGS, Rockville, MD) may soon have its first drug on the market. And thanks to a bold scale-up strategy, HGS?s manufacturing organization is ready.

Highly Similar

A single standard should apply to all comparability exercises for biologics, be they for biosimilars or manufacturing changes.
Jul 1, 2010

A single standard should apply to all comparability exercises for biologics, be they for biosimilars or manufacturing changes.

What We Learned from H1N1. Part 1: MedImmune

Jun 14, 2010

As part of a news series on the H1N1 influenza pandemic, BioPharm International interviewed Ben Machielse, Drs., executive vice president of operations at MedImmune, to ask about his company's experience manufacturing vaccines against H1N1.

What Will Pfizer Do With 79 Manufacturing Sites? Part 2: The Answer

Jun 10, 2010

In February, we reported on Pfizer's plans for reconfiguring its global manufacturing network of 79 plants, following its recent acquisition of Wyeth. Now, we have the answer.

The New Normal

New R&D models must be tried, but it will take time to see if they work. In the meantime, a new kind of threat is on the horizon: biobetters.
Jun 1, 2010

New R&D models must be tried, but it will take time to see if they work. In the meantime, a new kind of threat is on the horizon: biobetters.

MedImmune's Greenleaf on Biopharmaceutical Innovation and Biobetters

May 19, 2010

Now is not an easy time to lead a pharmaceutical company. The patent cliff is fast approaching, pipeline challenges remain, capital markets are tight, and the blockbuster model is fast on its way out. Meanwhile, regulations on sales and marketing continue to tighten.

Pandemic Response: Progress and Challenges

We all know that experience is the best teacher. With H1N1, we have a great opportunity to learn important lessons.
May 1, 2010

We all know that experience is the best teacher. With H1N1, we have a great opportunity to learn important lessons.

Preparing For an Uncertain Future

Given today's challenges, traditional strategies were bound to change. Now, there is one more big threat (or opportunity?) on the horizon.
Apr 1, 2010

Given today's challenges, traditional strategies were bound to change. Now, there is one more big threat (or opportunity?) on the horizon.

ADVERTISEMENT

ADVERTISEMENT

Click here